Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Evommune Inc. (EVMN) had Pre-Tax Income of $-32.25M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-32.25M |
|
-- |
|
-- |
|
$34.90M |
|
$-34.90M |
|
$2.65M |
|
|
Pre-Tax Income |
$-32.25M |
$-32.25M |
|
$-32.25M |
|
$-32.25M |
|
$-32.25M |
|
$-32.25M |
|
$-34.90M |
|
$-35.10M |
|
36.14M |
|
36.14M |
|
$-0.89 |
|
$-0.89 |
|
| Balance Sheet Financials | |
$204.25M |
|
$1.65M |
|
$97.70M |
|
$301.95M |
|
$17.49M |
|
$0.43M |
|
$6.87M |
|
$24.36M |
|
$277.59M |
|
$277.59M |
|
$277.59M |
|
36.28M |
|
| Cash Flow Statement Financials | |
$-47.82M |
|
$-54.06M |
|
$117.64M |
|
$45.48M |
|
$61.24M |
|
$15.76M |
|
$8.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.68 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-48.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.62% |
|
-11.62% |
|
-10.68% |
|
-11.60% |
|
$7.65 |
|
$-1.33 |
|
$-1.32 |
|